Latest Pulmonology Articles

• Progress through Persistence — Turning the Page in Pulmonary Fibrosis Clinical Trials May 19, 2025
  The field of pulmonary fibrosis has come a long way in the past 25 years, with the approach to patient care evolving from a predominantly experience-based decision-making model to a more data-driven model. Along that journey, we have learned that certain practices that were considered to be standards of care...
  Joyce S. Lee
• Nerandomilast in Patients with Progressive Pulmonary Fibrosis May 19, 2025
  In this randomized trial involving patients with progressive pulmonary fibrosis, treatment with nerandomilast led to a smaller decline in the forced vital capacity than placebo over a period of 52 weeks.
  Toby M. Maher, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold, Michael Kreuter, Justin M. Oldham, Luca Richeldi, Claudia Valenzuela, Marlies S. Wijsenbeek, Emmanuelle Clerisme-Beaty, Carl Coeck, Hui Gu, Ivana Ritter, Arno Schlosser, Susanne Stowasser, Florian Voss, Gerrit Weimann, Donald F. Zoz, Fernando J. Martinez, the FIBRONEER-ILD Trial Investigators*
• As-Needed Albuterol–Budesonide in Mild Asthma May 19, 2025
  In a randomized trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma.
  Craig LaForce, Frank Albers, Anna Danilewicz, Allison Jeynes-Ellis, Monica Kraft, Reynold A. Panettieri Jr., Robert Rees, Samuel Bardsley, Lynn Dunsire, Tim Harrison, Olami Sobande, Raulin Surujbally, Frank Trudo, Christy Cappelletti, Alberto Papi, Richard Beasley, Bradley E. Chipps, Elliot Israel, Hitesh Pandya, Martin Clancy, Leonard B. Bacharier, the BATURA Investigators*